COVID-19 Pill Paxlovid Moves Closer To Full FDA Approval

WASHINGTON (AP) — Pfizer’s COVID-19 pill Paxlovid won another vote of confidence from U.S. health advisers Thursday, clearing the way for its full regulatory approval by the Food and Drug Administration. The medication has been used by millions of Americans since the FDA granted it emergency use authorization in late 2021. The agency has the … Read more

FDA advisers vote in support of Paxlovid approval for Covid-19 treatment in high-risk adults

CNN  —  Advisers to the US Food and Drug Administration voted 16-1 on Thursday in support of full approval of Paxlovid, stating that the benefits outweigh any risks of the drug for treatment of mild to moderate Covid-19 in adults who are at high risk for severe disease, including hospitalization and death. Before the antiviral … Read more

COVID vaccine update: FDA authorizes Pfizer booster for some children under age five

Parents push back as hundreds of colleges still mandate COVID vaccines

The U.S. Food and Drug Administration (FDA) has authorized a single booster dose of the Pfizer-BioNTech COVID-19 vaccine bivalent for children six months old through four years of age. At least two months prior to getting this booster, children must have completed their three-dose primary vaccination series. Children in that age range who only received … Read more

Veru to proceed with late-stage study of COVID pill despite FDA snub

Fox News Flash top headlines for March 14

Drug developer Veru Inc on Tuesday said it plans to proceed with a late-stage trial of its COVID-19 pill, weeks after the U.S. health regulator declined to authorize the oral drug to treat high-risk patients hospitalized with COVID-19. It will, however, stop the development of the drug as a potential treatment for prostate cancer as … Read more